Global Oral Antidiabetic (OAD) Treatment Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Oral Antidiabetic (OAD) Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Oral Antidiabetic (OAD) Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Oral Antidiabetic (OAD) Treatment market. Oral Antidiabetic (OAD) Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oral Antidiabetic (OAD) Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oral Antidiabetic (OAD) Treatment market.
Diabetic is the condition where the sugar (glucose) level is high in the blood or the production of the insulin is inadequate. Diabetes main type the very first one is Type 1 and the second is Type 2, both the diabetic are most commonly find in the current scenario, apart from this many other diabetics case are also been listed as gestational diabetes and others. Various treatment method are present in the market injection, oral and others. The mostly used method of treatment or managing the diabetes is the oral.
North America has the 44.3 million population with diabetes in 2015 according to the IDF, same as Europe have 59.8 million in 2015 according to IDF and Asia Pacific has 60% diabetic population as compared with world according to Asian Diabetes Prevention Initiative.
Key Features:
The report on Oral Antidiabetic (OAD) Treatment market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oral Antidiabetic (OAD) Treatment market. It may include historical data, market segmentation by Type (e.g., Sulphonylureas, Biguanides), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oral Antidiabetic (OAD) Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oral Antidiabetic (OAD) Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oral Antidiabetic (OAD) Treatment industry. This include advancements in Oral Antidiabetic (OAD) Treatment technology, Oral Antidiabetic (OAD) Treatment new entrants, Oral Antidiabetic (OAD) Treatment new investment, and other innovations that are shaping the future of Oral Antidiabetic (OAD) Treatment.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oral Antidiabetic (OAD) Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Oral Antidiabetic (OAD) Treatment product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oral Antidiabetic (OAD) Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oral Antidiabetic (OAD) Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oral Antidiabetic (OAD) Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oral Antidiabetic (OAD) Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oral Antidiabetic (OAD) Treatment market.
Market Segmentation:
Oral Antidiabetic (OAD) Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Oral Antidiabetic (OAD) Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Oral Antidiabetic (OAD) Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Oral Antidiabetic (OAD) Treatment market. Oral Antidiabetic (OAD) Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oral Antidiabetic (OAD) Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oral Antidiabetic (OAD) Treatment market.
Diabetic is the condition where the sugar (glucose) level is high in the blood or the production of the insulin is inadequate. Diabetes main type the very first one is Type 1 and the second is Type 2, both the diabetic are most commonly find in the current scenario, apart from this many other diabetics case are also been listed as gestational diabetes and others. Various treatment method are present in the market injection, oral and others. The mostly used method of treatment or managing the diabetes is the oral.
North America has the 44.3 million population with diabetes in 2015 according to the IDF, same as Europe have 59.8 million in 2015 according to IDF and Asia Pacific has 60% diabetic population as compared with world according to Asian Diabetes Prevention Initiative.
Key Features:
The report on Oral Antidiabetic (OAD) Treatment market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oral Antidiabetic (OAD) Treatment market. It may include historical data, market segmentation by Type (e.g., Sulphonylureas, Biguanides), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oral Antidiabetic (OAD) Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oral Antidiabetic (OAD) Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oral Antidiabetic (OAD) Treatment industry. This include advancements in Oral Antidiabetic (OAD) Treatment technology, Oral Antidiabetic (OAD) Treatment new entrants, Oral Antidiabetic (OAD) Treatment new investment, and other innovations that are shaping the future of Oral Antidiabetic (OAD) Treatment.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oral Antidiabetic (OAD) Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Oral Antidiabetic (OAD) Treatment product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oral Antidiabetic (OAD) Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oral Antidiabetic (OAD) Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oral Antidiabetic (OAD) Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oral Antidiabetic (OAD) Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oral Antidiabetic (OAD) Treatment market.
Market Segmentation:
Oral Antidiabetic (OAD) Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Sulphonylureas
- Biguanides
- Intestinal ?-Glucosidase Inhibitors
- Others
- Hospital
- Clinics
- Diabetics Treatment Centres
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Eli Lilly
- Merck
- Sanofi
- AstraZeneca
- Glenmark
- Novartis
- Boehringer Ingelheim
- Novo Nordisk
- Mannkind
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Antidiabetic (OAD) Treatment Market Size 2019-2030
2.1.2 Oral Antidiabetic (OAD) Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Oral Antidiabetic (OAD) Treatment Segment by Type
2.2.1 Sulphonylureas
2.2.2 Biguanides
2.2.3 Intestinal ?-Glucosidase Inhibitors
2.2.4 Others
2.3 Oral Antidiabetic (OAD) Treatment Market Size by Type
2.3.1 Oral Antidiabetic (OAD) Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2019-2024)
2.4 Oral Antidiabetic (OAD) Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Diabetics Treatment Centres
2.4.4 Others
2.5 Oral Antidiabetic (OAD) Treatment Market Size by Application
2.5.1 Oral Antidiabetic (OAD) Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2019-2024)
3 ORAL ANTIDIABETIC (OAD) TREATMENT MARKET SIZE BY PLAYER
3.1 Oral Antidiabetic (OAD) Treatment Market Size Market Share by Players
3.1.1 Global Oral Antidiabetic (OAD) Treatment Revenue by Players (2019-2024)
3.1.2 Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Oral Antidiabetic (OAD) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ORAL ANTIDIABETIC (OAD) TREATMENT BY REGIONS
4.1 Oral Antidiabetic (OAD) Treatment Market Size by Regions (2019-2024)
4.2 Americas Oral Antidiabetic (OAD) Treatment Market Size Growth (2019-2024)
4.3 APAC Oral Antidiabetic (OAD) Treatment Market Size Growth (2019-2024)
4.4 Europe Oral Antidiabetic (OAD) Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Oral Antidiabetic (OAD) Treatment Market Size by Country (2019-2024)
5.2 Americas Oral Antidiabetic (OAD) Treatment Market Size by Type (2019-2024)
5.3 Americas Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Antidiabetic (OAD) Treatment Market Size by Region (2019-2024)
6.2 APAC Oral Antidiabetic (OAD) Treatment Market Size by Type (2019-2024)
6.3 APAC Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oral Antidiabetic (OAD) Treatment by Country (2019-2024)
7.2 Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2019-2024)
7.3 Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Antidiabetic (OAD) Treatment by Region (2019-2024)
8.2 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ORAL ANTIDIABETIC (OAD) TREATMENT MARKET FORECAST
10.1 Global Oral Antidiabetic (OAD) Treatment Forecast by Regions (2025-2030)
10.1.1 Global Oral Antidiabetic (OAD) Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Oral Antidiabetic (OAD) Treatment Forecast
10.1.3 APAC Oral Antidiabetic (OAD) Treatment Forecast
10.1.4 Europe Oral Antidiabetic (OAD) Treatment Forecast
10.1.5 Middle East & Africa Oral Antidiabetic (OAD) Treatment Forecast
10.2 Americas Oral Antidiabetic (OAD) Treatment Forecast by Country (2025-2030)
10.2.1 United States Oral Antidiabetic (OAD) Treatment Market Forecast
10.2.2 Canada Oral Antidiabetic (OAD) Treatment Market Forecast
10.2.3 Mexico Oral Antidiabetic (OAD) Treatment Market Forecast
10.2.4 Brazil Oral Antidiabetic (OAD) Treatment Market Forecast
10.3 APAC Oral Antidiabetic (OAD) Treatment Forecast by Region (2025-2030)
10.3.1 China Oral Antidiabetic (OAD) Treatment Market Forecast
10.3.2 Japan Oral Antidiabetic (OAD) Treatment Market Forecast
10.3.3 Korea Oral Antidiabetic (OAD) Treatment Market Forecast
10.3.4 Southeast Asia Oral Antidiabetic (OAD) Treatment Market Forecast
10.3.5 India Oral Antidiabetic (OAD) Treatment Market Forecast
10.3.6 Australia Oral Antidiabetic (OAD) Treatment Market Forecast
10.4 Europe Oral Antidiabetic (OAD) Treatment Forecast by Country (2025-2030)
10.4.1 Germany Oral Antidiabetic (OAD) Treatment Market Forecast
10.4.2 France Oral Antidiabetic (OAD) Treatment Market Forecast
10.4.3 UK Oral Antidiabetic (OAD) Treatment Market Forecast
10.4.4 Italy Oral Antidiabetic (OAD) Treatment Market Forecast
10.4.5 Russia Oral Antidiabetic (OAD) Treatment Market Forecast
10.5 Middle East & Africa Oral Antidiabetic (OAD) Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Oral Antidiabetic (OAD) Treatment Market Forecast
10.5.2 South Africa Oral Antidiabetic (OAD) Treatment Market Forecast
10.5.3 Israel Oral Antidiabetic (OAD) Treatment Market Forecast
10.5.4 Turkey Oral Antidiabetic (OAD) Treatment Market Forecast
10.5.5 GCC Countries Oral Antidiabetic (OAD) Treatment Market Forecast
10.6 Global Oral Antidiabetic (OAD) Treatment Forecast by Type (2025-2030)
10.7 Global Oral Antidiabetic (OAD) Treatment Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Oral Antidiabetic (OAD) Treatment Product Offered
11.1.3 Pfizer Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Information
11.2.2 Eli Lilly Oral Antidiabetic (OAD) Treatment Product Offered
11.2.3 Eli Lilly Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Eli Lilly Main Business Overview
11.2.5 Eli Lilly Latest Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Oral Antidiabetic (OAD) Treatment Product Offered
11.3.3 Merck Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Merck Main Business Overview
11.3.5 Merck Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Oral Antidiabetic (OAD) Treatment Product Offered
11.4.3 Sanofi Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Oral Antidiabetic (OAD) Treatment Product Offered
11.5.3 AstraZeneca Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 Glenmark
11.6.1 Glenmark Company Information
11.6.2 Glenmark Oral Antidiabetic (OAD) Treatment Product Offered
11.6.3 Glenmark Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Glenmark Main Business Overview
11.6.5 Glenmark Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Oral Antidiabetic (OAD) Treatment Product Offered
11.7.3 Novartis Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Information
11.8.2 Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Product Offered
11.8.3 Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Boehringer Ingelheim Main Business Overview
11.8.5 Boehringer Ingelheim Latest Developments
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Information
11.9.2 Novo Nordisk Oral Antidiabetic (OAD) Treatment Product Offered
11.9.3 Novo Nordisk Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Novo Nordisk Main Business Overview
11.9.5 Novo Nordisk Latest Developments
11.10 Mannkind
11.10.1 Mannkind Company Information
11.10.2 Mannkind Oral Antidiabetic (OAD) Treatment Product Offered
11.10.3 Mannkind Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Mannkind Main Business Overview
11.10.5 Mannkind Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Antidiabetic (OAD) Treatment Market Size 2019-2030
2.1.2 Oral Antidiabetic (OAD) Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Oral Antidiabetic (OAD) Treatment Segment by Type
2.2.1 Sulphonylureas
2.2.2 Biguanides
2.2.3 Intestinal ?-Glucosidase Inhibitors
2.2.4 Others
2.3 Oral Antidiabetic (OAD) Treatment Market Size by Type
2.3.1 Oral Antidiabetic (OAD) Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2019-2024)
2.4 Oral Antidiabetic (OAD) Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Diabetics Treatment Centres
2.4.4 Others
2.5 Oral Antidiabetic (OAD) Treatment Market Size by Application
2.5.1 Oral Antidiabetic (OAD) Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2019-2024)
3 ORAL ANTIDIABETIC (OAD) TREATMENT MARKET SIZE BY PLAYER
3.1 Oral Antidiabetic (OAD) Treatment Market Size Market Share by Players
3.1.1 Global Oral Antidiabetic (OAD) Treatment Revenue by Players (2019-2024)
3.1.2 Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Oral Antidiabetic (OAD) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ORAL ANTIDIABETIC (OAD) TREATMENT BY REGIONS
4.1 Oral Antidiabetic (OAD) Treatment Market Size by Regions (2019-2024)
4.2 Americas Oral Antidiabetic (OAD) Treatment Market Size Growth (2019-2024)
4.3 APAC Oral Antidiabetic (OAD) Treatment Market Size Growth (2019-2024)
4.4 Europe Oral Antidiabetic (OAD) Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Oral Antidiabetic (OAD) Treatment Market Size by Country (2019-2024)
5.2 Americas Oral Antidiabetic (OAD) Treatment Market Size by Type (2019-2024)
5.3 Americas Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Antidiabetic (OAD) Treatment Market Size by Region (2019-2024)
6.2 APAC Oral Antidiabetic (OAD) Treatment Market Size by Type (2019-2024)
6.3 APAC Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oral Antidiabetic (OAD) Treatment by Country (2019-2024)
7.2 Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2019-2024)
7.3 Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Antidiabetic (OAD) Treatment by Region (2019-2024)
8.2 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ORAL ANTIDIABETIC (OAD) TREATMENT MARKET FORECAST
10.1 Global Oral Antidiabetic (OAD) Treatment Forecast by Regions (2025-2030)
10.1.1 Global Oral Antidiabetic (OAD) Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Oral Antidiabetic (OAD) Treatment Forecast
10.1.3 APAC Oral Antidiabetic (OAD) Treatment Forecast
10.1.4 Europe Oral Antidiabetic (OAD) Treatment Forecast
10.1.5 Middle East & Africa Oral Antidiabetic (OAD) Treatment Forecast
10.2 Americas Oral Antidiabetic (OAD) Treatment Forecast by Country (2025-2030)
10.2.1 United States Oral Antidiabetic (OAD) Treatment Market Forecast
10.2.2 Canada Oral Antidiabetic (OAD) Treatment Market Forecast
10.2.3 Mexico Oral Antidiabetic (OAD) Treatment Market Forecast
10.2.4 Brazil Oral Antidiabetic (OAD) Treatment Market Forecast
10.3 APAC Oral Antidiabetic (OAD) Treatment Forecast by Region (2025-2030)
10.3.1 China Oral Antidiabetic (OAD) Treatment Market Forecast
10.3.2 Japan Oral Antidiabetic (OAD) Treatment Market Forecast
10.3.3 Korea Oral Antidiabetic (OAD) Treatment Market Forecast
10.3.4 Southeast Asia Oral Antidiabetic (OAD) Treatment Market Forecast
10.3.5 India Oral Antidiabetic (OAD) Treatment Market Forecast
10.3.6 Australia Oral Antidiabetic (OAD) Treatment Market Forecast
10.4 Europe Oral Antidiabetic (OAD) Treatment Forecast by Country (2025-2030)
10.4.1 Germany Oral Antidiabetic (OAD) Treatment Market Forecast
10.4.2 France Oral Antidiabetic (OAD) Treatment Market Forecast
10.4.3 UK Oral Antidiabetic (OAD) Treatment Market Forecast
10.4.4 Italy Oral Antidiabetic (OAD) Treatment Market Forecast
10.4.5 Russia Oral Antidiabetic (OAD) Treatment Market Forecast
10.5 Middle East & Africa Oral Antidiabetic (OAD) Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Oral Antidiabetic (OAD) Treatment Market Forecast
10.5.2 South Africa Oral Antidiabetic (OAD) Treatment Market Forecast
10.5.3 Israel Oral Antidiabetic (OAD) Treatment Market Forecast
10.5.4 Turkey Oral Antidiabetic (OAD) Treatment Market Forecast
10.5.5 GCC Countries Oral Antidiabetic (OAD) Treatment Market Forecast
10.6 Global Oral Antidiabetic (OAD) Treatment Forecast by Type (2025-2030)
10.7 Global Oral Antidiabetic (OAD) Treatment Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Oral Antidiabetic (OAD) Treatment Product Offered
11.1.3 Pfizer Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Information
11.2.2 Eli Lilly Oral Antidiabetic (OAD) Treatment Product Offered
11.2.3 Eli Lilly Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Eli Lilly Main Business Overview
11.2.5 Eli Lilly Latest Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Oral Antidiabetic (OAD) Treatment Product Offered
11.3.3 Merck Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Merck Main Business Overview
11.3.5 Merck Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Oral Antidiabetic (OAD) Treatment Product Offered
11.4.3 Sanofi Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Oral Antidiabetic (OAD) Treatment Product Offered
11.5.3 AstraZeneca Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 Glenmark
11.6.1 Glenmark Company Information
11.6.2 Glenmark Oral Antidiabetic (OAD) Treatment Product Offered
11.6.3 Glenmark Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Glenmark Main Business Overview
11.6.5 Glenmark Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Oral Antidiabetic (OAD) Treatment Product Offered
11.7.3 Novartis Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Information
11.8.2 Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Product Offered
11.8.3 Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Boehringer Ingelheim Main Business Overview
11.8.5 Boehringer Ingelheim Latest Developments
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Information
11.9.2 Novo Nordisk Oral Antidiabetic (OAD) Treatment Product Offered
11.9.3 Novo Nordisk Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Novo Nordisk Main Business Overview
11.9.5 Novo Nordisk Latest Developments
11.10 Mannkind
11.10.1 Mannkind Company Information
11.10.2 Mannkind Oral Antidiabetic (OAD) Treatment Product Offered
11.10.3 Mannkind Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Mannkind Main Business Overview
11.10.5 Mannkind Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oral Antidiabetic (OAD) Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Sulphonylureas
Table 3. Major Players of Biguanides
Table 4. Major Players of Intestinal ?-Glucosidase Inhibitors
Table 5. Major Players of Others
Table 6. Oral Antidiabetic (OAD) Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Oral Antidiabetic (OAD) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2019-2024)
Table 9. Oral Antidiabetic (OAD) Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2019-2024)
Table 12. Global Oral Antidiabetic (OAD) Treatment Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Player (2019-2024)
Table 14. Oral Antidiabetic (OAD) Treatment Key Players Head office and Products Offered
Table 15. Oral Antidiabetic (OAD) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Oral Antidiabetic (OAD) Treatment Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Regions (2019-2024)
Table 20. Global Oral Antidiabetic (OAD) Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Oral Antidiabetic (OAD) Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Oral Antidiabetic (OAD) Treatment Market Size Market Share by Country (2019-2024)
Table 24. Americas Oral Antidiabetic (OAD) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2019-2024)
Table 26. Americas Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2019-2024)
Table 28. APAC Oral Antidiabetic (OAD) Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Oral Antidiabetic (OAD) Treatment Market Size Market Share by Region (2019-2024)
Table 30. APAC Oral Antidiabetic (OAD) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2019-2024)
Table 32. APAC Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2019-2024)
Table 34. Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Oral Antidiabetic (OAD) Treatment Market Size Market Share by Country (2019-2024)
Table 36. Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2019-2024)
Table 38. Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Oral Antidiabetic (OAD) Treatment
Table 47. Key Market Challenges & Risks of Oral Antidiabetic (OAD) Treatment
Table 48. Key Industry Trends of Oral Antidiabetic (OAD) Treatment
Table 49. Global Oral Antidiabetic (OAD) Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Oral Antidiabetic (OAD) Treatment Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Oral Antidiabetic (OAD) Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Oral Antidiabetic (OAD) Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Pfizer Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 54. Pfizer Oral Antidiabetic (OAD) Treatment Product Offered
Table 55. Pfizer Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Pfizer Main Business
Table 57. Pfizer Latest Developments
Table 58. Eli Lilly Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 59. Eli Lilly Oral Antidiabetic (OAD) Treatment Product Offered
Table 60. Eli Lilly Main Business
Table 61. Eli Lilly Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Eli Lilly Latest Developments
Table 63. Merck Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 64. Merck Oral Antidiabetic (OAD) Treatment Product Offered
Table 65. Merck Main Business
Table 66. Merck Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Merck Latest Developments
Table 68. Sanofi Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 69. Sanofi Oral Antidiabetic (OAD) Treatment Product Offered
Table 70. Sanofi Main Business
Table 71. Sanofi Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Sanofi Latest Developments
Table 73. AstraZeneca Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 74. AstraZeneca Oral Antidiabetic (OAD) Treatment Product Offered
Table 75. AstraZeneca Main Business
Table 76. AstraZeneca Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. AstraZeneca Latest Developments
Table 78. Glenmark Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 79. Glenmark Oral Antidiabetic (OAD) Treatment Product Offered
Table 80. Glenmark Main Business
Table 81. Glenmark Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Glenmark Latest Developments
Table 83. Novartis Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 84. Novartis Oral Antidiabetic (OAD) Treatment Product Offered
Table 85. Novartis Main Business
Table 86. Novartis Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Novartis Latest Developments
Table 88. Boehringer Ingelheim Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 89. Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Product Offered
Table 90. Boehringer Ingelheim Main Business
Table 91. Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Boehringer Ingelheim Latest Developments
Table 93. Novo Nordisk Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 94. Novo Nordisk Oral Antidiabetic (OAD) Treatment Product Offered
Table 95. Novo Nordisk Main Business
Table 96. Novo Nordisk Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Novo Nordisk Latest Developments
Table 98. Mannkind Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 99. Mannkind Oral Antidiabetic (OAD) Treatment Product Offered
Table 100. Mannkind Main Business
Table 101. Mannkind Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Mannkind Latest Developments
Table 1. Oral Antidiabetic (OAD) Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Sulphonylureas
Table 3. Major Players of Biguanides
Table 4. Major Players of Intestinal ?-Glucosidase Inhibitors
Table 5. Major Players of Others
Table 6. Oral Antidiabetic (OAD) Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Oral Antidiabetic (OAD) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2019-2024)
Table 9. Oral Antidiabetic (OAD) Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2019-2024)
Table 12. Global Oral Antidiabetic (OAD) Treatment Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Player (2019-2024)
Table 14. Oral Antidiabetic (OAD) Treatment Key Players Head office and Products Offered
Table 15. Oral Antidiabetic (OAD) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Oral Antidiabetic (OAD) Treatment Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Regions (2019-2024)
Table 20. Global Oral Antidiabetic (OAD) Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Oral Antidiabetic (OAD) Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Oral Antidiabetic (OAD) Treatment Market Size Market Share by Country (2019-2024)
Table 24. Americas Oral Antidiabetic (OAD) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2019-2024)
Table 26. Americas Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2019-2024)
Table 28. APAC Oral Antidiabetic (OAD) Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Oral Antidiabetic (OAD) Treatment Market Size Market Share by Region (2019-2024)
Table 30. APAC Oral Antidiabetic (OAD) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2019-2024)
Table 32. APAC Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2019-2024)
Table 34. Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Oral Antidiabetic (OAD) Treatment Market Size Market Share by Country (2019-2024)
Table 36. Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2019-2024)
Table 38. Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Oral Antidiabetic (OAD) Treatment
Table 47. Key Market Challenges & Risks of Oral Antidiabetic (OAD) Treatment
Table 48. Key Industry Trends of Oral Antidiabetic (OAD) Treatment
Table 49. Global Oral Antidiabetic (OAD) Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Oral Antidiabetic (OAD) Treatment Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Oral Antidiabetic (OAD) Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Oral Antidiabetic (OAD) Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Pfizer Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 54. Pfizer Oral Antidiabetic (OAD) Treatment Product Offered
Table 55. Pfizer Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Pfizer Main Business
Table 57. Pfizer Latest Developments
Table 58. Eli Lilly Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 59. Eli Lilly Oral Antidiabetic (OAD) Treatment Product Offered
Table 60. Eli Lilly Main Business
Table 61. Eli Lilly Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Eli Lilly Latest Developments
Table 63. Merck Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 64. Merck Oral Antidiabetic (OAD) Treatment Product Offered
Table 65. Merck Main Business
Table 66. Merck Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Merck Latest Developments
Table 68. Sanofi Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 69. Sanofi Oral Antidiabetic (OAD) Treatment Product Offered
Table 70. Sanofi Main Business
Table 71. Sanofi Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Sanofi Latest Developments
Table 73. AstraZeneca Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 74. AstraZeneca Oral Antidiabetic (OAD) Treatment Product Offered
Table 75. AstraZeneca Main Business
Table 76. AstraZeneca Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. AstraZeneca Latest Developments
Table 78. Glenmark Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 79. Glenmark Oral Antidiabetic (OAD) Treatment Product Offered
Table 80. Glenmark Main Business
Table 81. Glenmark Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Glenmark Latest Developments
Table 83. Novartis Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 84. Novartis Oral Antidiabetic (OAD) Treatment Product Offered
Table 85. Novartis Main Business
Table 86. Novartis Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Novartis Latest Developments
Table 88. Boehringer Ingelheim Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 89. Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Product Offered
Table 90. Boehringer Ingelheim Main Business
Table 91. Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Boehringer Ingelheim Latest Developments
Table 93. Novo Nordisk Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 94. Novo Nordisk Oral Antidiabetic (OAD) Treatment Product Offered
Table 95. Novo Nordisk Main Business
Table 96. Novo Nordisk Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Novo Nordisk Latest Developments
Table 98. Mannkind Details, Company Type, Oral Antidiabetic (OAD) Treatment Area Served and Its Competitors
Table 99. Mannkind Oral Antidiabetic (OAD) Treatment Product Offered
Table 100. Mannkind Main Business
Table 101. Mannkind Oral Antidiabetic (OAD) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Mannkind Latest Developments
LIST OF FIGURES
Figure 1. Oral Antidiabetic (OAD) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Oral Antidiabetic (OAD) Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Oral Antidiabetic (OAD) Treatment Sales Market Share by Country/Region (2023)
Figure 8. Oral Antidiabetic (OAD) Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type in 2023
Figure 10. Oral Antidiabetic (OAD) Treatment in Hospital
Figure 11. Global Oral Antidiabetic (OAD) Treatment Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Oral Antidiabetic (OAD) Treatment in Clinics
Figure 13. Global Oral Antidiabetic (OAD) Treatment Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Oral Antidiabetic (OAD) Treatment in Diabetics Treatment Centres
Figure 15. Global Oral Antidiabetic (OAD) Treatment Market: Diabetics Treatment Centres (2019-2024) & ($ Millions)
Figure 16. Oral Antidiabetic (OAD) Treatment in Others
Figure 17. Global Oral Antidiabetic (OAD) Treatment Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application in 2023
Figure 19. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Player in 2023
Figure 20. Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Oral Antidiabetic (OAD) Treatment Market Size 2019-2024 ($ Millions)
Figure 22. APAC Oral Antidiabetic (OAD) Treatment Market Size 2019-2024 ($ Millions)
Figure 23. Europe Oral Antidiabetic (OAD) Treatment Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size 2019-2024 ($ Millions)
Figure 25. Americas Oral Antidiabetic (OAD) Treatment Value Market Share by Country in 2023
Figure 26. United States Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Oral Antidiabetic (OAD) Treatment Market Size Market Share by Region in 2023
Figure 31. APAC Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type in 2023
Figure 32. APAC Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application in 2023
Figure 33. China Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Oral Antidiabetic (OAD) Treatment Market Size Market Share by Country in 2023
Figure 40. Europe Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2019-2024)
Figure 41. Europe Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2019-2024)
Figure 42. Germany Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 56. APAC Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 57. Europe Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 59. United States Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 60. Canada Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 63. China Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 64. Japan Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 65. Korea Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 67. India Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 68. Australia Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 69. Germany Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 70. France Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 71. UK Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 72. Italy Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 73. Russia Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 74. Spain Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 77. Israel Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 80. Global Oral Antidiabetic (OAD) Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Oral Antidiabetic (OAD) Treatment Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Oral Antidiabetic (OAD) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Oral Antidiabetic (OAD) Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Oral Antidiabetic (OAD) Treatment Sales Market Share by Country/Region (2023)
Figure 8. Oral Antidiabetic (OAD) Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type in 2023
Figure 10. Oral Antidiabetic (OAD) Treatment in Hospital
Figure 11. Global Oral Antidiabetic (OAD) Treatment Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Oral Antidiabetic (OAD) Treatment in Clinics
Figure 13. Global Oral Antidiabetic (OAD) Treatment Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Oral Antidiabetic (OAD) Treatment in Diabetics Treatment Centres
Figure 15. Global Oral Antidiabetic (OAD) Treatment Market: Diabetics Treatment Centres (2019-2024) & ($ Millions)
Figure 16. Oral Antidiabetic (OAD) Treatment in Others
Figure 17. Global Oral Antidiabetic (OAD) Treatment Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application in 2023
Figure 19. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Player in 2023
Figure 20. Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Oral Antidiabetic (OAD) Treatment Market Size 2019-2024 ($ Millions)
Figure 22. APAC Oral Antidiabetic (OAD) Treatment Market Size 2019-2024 ($ Millions)
Figure 23. Europe Oral Antidiabetic (OAD) Treatment Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size 2019-2024 ($ Millions)
Figure 25. Americas Oral Antidiabetic (OAD) Treatment Value Market Share by Country in 2023
Figure 26. United States Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Oral Antidiabetic (OAD) Treatment Market Size Market Share by Region in 2023
Figure 31. APAC Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type in 2023
Figure 32. APAC Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application in 2023
Figure 33. China Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Oral Antidiabetic (OAD) Treatment Market Size Market Share by Country in 2023
Figure 40. Europe Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2019-2024)
Figure 41. Europe Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2019-2024)
Figure 42. Germany Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Oral Antidiabetic (OAD) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 56. APAC Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 57. Europe Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 59. United States Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 60. Canada Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 63. China Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 64. Japan Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 65. Korea Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 67. India Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 68. Australia Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 69. Germany Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 70. France Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 71. UK Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 72. Italy Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 73. Russia Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 74. Spain Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 77. Israel Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Oral Antidiabetic (OAD) Treatment Market Size 2025-2030 ($ Millions)
Figure 80. Global Oral Antidiabetic (OAD) Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Oral Antidiabetic (OAD) Treatment Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Soft Tissue Membrane Market Growth 2023-2029
US$ 3,660.00
March 2023
105 pages
Global Feline Mouth Gags Market Growth 2024-2030
US$ 3,660.00
September 2024
119 pages
Global Intraoral Imaging Systems Market Growth 2024-2030
US$ 3,660.00
June 2024
88 pages
